Eradication of hepatitis C virus infection in thalassemia patients in Iran using various treatment strategies

BACKGROUND: Chronic hepatitis C virus (HCV) infection is considered as one of the leading causes of liver disease in thalassemic patients in Iran. Over 40% of the mortality in these patients is related to HCV. OBJECTIVES: The present study aimed at estimating HCV prevalence in thalassemic patients i...

Descripción completa

Detalles Bibliográficos
Autores principales: Moghimbeygi, Meisam, Alavian, Seyed Moayed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646675/
https://www.ncbi.nlm.nih.gov/pubmed/33251024
http://dx.doi.org/10.1016/j.jve.2020.100006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646675/
https://www.ncbi.nlm.nih.gov/pubmed/33251024
http://dx.doi.org/10.1016/j.jve.2020.100006

Ejemplares similares